Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Lung Cancer

  Free Subscription


Articles published in JAMA Oncol

Retrieve available abstracts of 30 articles:
HTML format
Text format



Single Articles


    June 2019
  1. ALDRICH MC, Mercaldo SF, Sandler KL, Blot WJ, et al
    Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers.
    JAMA Oncol. 2019 Jun 27. pii: 2737091. doi: 10.1001/jamaoncol.2019.1402.
    PubMed     Text format     Abstract available


  2. SALEM A, Faivre-Finn C
    Time to Change the Limited-Stage Paradigm for Small Cell Lung Cancer?-In Reply.
    JAMA Oncol. 2019 Jun 20. pii: 2736365. doi: 10.1001/jamaoncol.2019.1332.
    PubMed     Text format    


  3. CHUN SG, Schild SE, Bogart JA
    Time to Change the Limited-Stage Paradigm for Small Cell Lung Cancer?
    JAMA Oncol. 2019 Jun 20. pii: 2736364. doi: 10.1001/jamaoncol.2019.1326.
    PubMed     Text format    


    May 2019
  4. GIRI S, Huntington SF
    Changes to Model Assumptions of the Cost-effectiveness of Durvalumab Therapy for Non-Small Cell Lung Cancer.
    JAMA Oncol. 2019 May 16. pii: 2733792. doi: 10.1001/jamaoncol.2019.1088.
    PubMed     Text format    


  5. CRISS SD, Mooradian MJ, Kong CY
    Changes to Model Assumptions of the Cost-effectiveness of Durvalumab Therapy for Non-Small Cell Lung Cancer-In Reply.
    JAMA Oncol. 2019 May 16. pii: 2733793. doi: 10.1001/jamaoncol.2019.1100.
    PubMed     Text format    


    April 2019
  6. BERNER F, Bomze D, Diem S, Ali OH, et al
    Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer.
    JAMA Oncol. 2019 Apr 25. pii: 2731134. doi: 10.1001/jamaoncol.2019.0402.
    PubMed     Text format     Abstract available


    March 2019
  7. MOR V, Wagner TH, Levy C, Ersek M, et al
    Association of Expanded VA Hospice Care With Aggressive Care and Cost for Veterans With Advanced Lung Cancer.
    JAMA Oncol. 2019 Mar 28. pii: 2729064. doi: 10.1001/jamaoncol.2019.0081.
    PubMed     Text format     Abstract available


  8. SUN A, Hu C, Wong SJ, Gore E, et al
    Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.
    JAMA Oncol. 2019 Mar 14. pii: 2728245. doi: 10.1001/jamaoncol.2018.7220.
    PubMed     Text format     Abstract available


    February 2019
  9. WANG Z, Duan J, Cai S, Han M, et al
    Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.
    JAMA Oncol. 2019 Feb 28. pii: 2726029. doi: 10.1001/jamaoncol.2018.7098.
    PubMed     Text format     Abstract available


  10. PALMA DA, Nguyen TK, Louie AV, Malthaner R, et al
    Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
    JAMA Oncol. 2019 Feb 21. pii: 2725402. doi: 10.1001/jamaoncol.2018.6993.
    PubMed     Text format     Abstract available


    December 2018
  11. TOI Y, Sugawara S, Sugisaka J, Ono H, et al
    Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.
    JAMA Oncol. 2018 Dec 27. pii: 2718925. doi: 10.1001/jamaoncol.2018.5860.
    PubMed     Text format     Abstract available


  12. CRISS SD, Mooradian MJ, Sheehan DF, Zubiri L, et al
    Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System.
    JAMA Oncol. 2018 Dec 13. pii: 2718006. doi: 10.1001/jamaoncol.2018.5449.
    PubMed     Text format     Abstract available


  13. SALEM A, Mistry H, Hatton M, Locke I, et al
    Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial.
    JAMA Oncol. 2018 Dec 6:e185335. doi: 10.1001/jamaoncol.2018.5335.
    PubMed     Text format     Abstract available


  14. WEST HJ
    Moving Beyond Limited and Extensive Staging of Small Cell Lung Cancer.
    JAMA Oncol. 2018 Dec 6. pii: 2717231. doi: 10.1001/jamaoncol.2018.5187.
    PubMed     Text format    


    November 2018
  15. CHEN XZ
    Anlotinib for Refractory Advanced Non-Small Cell Lung Cancer in China.
    JAMA Oncol. 2018 Nov 29. pii: 2716809. doi: 10.1001/jamaoncol.2018.5526.
    PubMed     Text format    


  16. SLOAN L, Romo CG, Hales RK
    Hemifacial Hyperhidrosis in a Patient With an Apical Non-Small Cell Lung Cancer.
    JAMA Oncol. 2018 Nov 15. pii: 2713851. doi: 10.1001/jamaoncol.2018.4597.
    PubMed     Text format    


    October 2018
  17. EZE C, Kasmann L, Manapov F
    Redefining the Role of Prophylactic Cranial Irradiation in the Modern Era of Active Surveillance in Small Cell Lung Cancer.
    JAMA Oncol. 2018 Oct 25. pii: 2707226. doi: 10.1001/jamaoncol.2018.4833.
    PubMed     Text format    


  18. GYAWALI B, West HJ
    Plasma vs Tissue Next-Generation Sequencing in Non-Small Cell Lung Cancer-Either, Both, or Neither?
    JAMA Oncol. 2018 Oct 11. pii: 2705603. doi: 10.1001/jamaoncol.2018.4304.
    PubMed     Text format    


  19. AGGARWAL C, Thompson JC, Black TA, Katz SI, et al
    Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.
    JAMA Oncol. 2018 Oct 11. pii: 2705609. doi: 10.1001/jamaoncol.2018.4305.
    PubMed     Text format     Abstract available


  20. BOOZALIS E, Kwatra SG, Marrone KA
    Bilateral Lower Extremity Skin Eruptions in an HIV-Positive Man Receiving Pembrolizumab Monotherapy for Non-Small Cell Lung Cancer.
    JAMA Oncol. 2018 Oct 4. pii: 2704206. doi: 10.1001/jamaoncol.2018.4485.
    PubMed     Text format    


    September 2018
  21. TUMINELLO S, Schwartz RM, Liu B, Mhango G, et al
    Opioid Use After Open Resection or Video-Assisted Thoracoscopic Surgery for Early-Stage Lung Cancer.
    JAMA Oncol. 2018 Sep 24. pii: 2703444. doi: 10.1001/jamaoncol.2018.4387.
    PubMed     Text format    


  22. FERRARA R, Mezquita L, Texier M, Lahmar J, et al
    Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.
    JAMA Oncol. 2018 Sep 6. pii: 2698845. doi: 10.1001/jamaoncol.2018.3676.
    PubMed     Text format     Abstract available


    August 2018
  23. GRIDELLI C, de Castro Carpeno J, Dingemans AC, Griesinger F, et al
    Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial.
    JAMA Oncol. 2018 Aug 30:e183486. doi: 10.1001/jamaoncol.2018.3486.
    PubMed     Text format     Abstract available


  24. HAN B, Li K, Wang Q, Zhang L, et al
    Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial.
    JAMA Oncol. 2018 Aug 9. pii: 2696341. doi: 10.1001/jamaoncol.2018.3039.
    PubMed     Text format     Abstract available


  25. ALCORN SR, Miller DB, Hales RK
    Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer.
    JAMA Oncol. 2018 Aug 2. pii: 2694876. doi: 10.1001/jamaoncol.2018.3261.
    PubMed     Text format    


  26. PASQUINELLI MM, Kovitz KL, Koshy M, Menchaca MG, et al
    Outcomes From a Minority-Based Lung Cancer Screening Program vs the National Lung Screening Trial.
    JAMA Oncol. 2018 Aug 2. pii: 2694875. doi: 10.1001/jamaoncol.2018.2823.
    PubMed     Text format    


  27. CHUN SG, Pezzi TA, Schwartz DL
    Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer-Reply.
    JAMA Oncol. 2018 Aug 2. pii: 2694877. doi: 10.1001/jamaoncol.2018.3292.
    PubMed     Text format    


  28. OXNARD GR, Hu Y, Mileham KF, Husain H, et al
    Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib.
    JAMA Oncol. 2018 Aug 2. pii: 2694879. doi: 10.1001/jamaoncol.2018.2969.
    PubMed     Text format     Abstract available


    July 2018
  29. GUIDA F, Sun N, Bantis LE, Muller DC, et al
    Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.
    JAMA Oncol. 2018 Jul 12:e182078. doi: 10.1001/jamaoncol.2018.2078.
    PubMed     Text format     Abstract available


    June 2018
  30. GANDARA DR, Riess JW, Lara PN Jr
    In Search of an Oncogene Driver for Squamous Lung Cancer.
    JAMA Oncol. 2018 Jun 14. pii: 2684629. doi: 10.1001/jamaoncol.2018.0774.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: